Authors: PORTER D BODDY A THOMAS H LIND M NEWELL D CALVERT AH ROBSON L BRAMPTON M ABRAHAMSEN D WINOGRAD B

Citation: D. Porter et al., ETOPOSIDE PHOSPHATE INFUSION WITH THERAPEUTIC DRUG-MONITORING IN COMBINATION WITH CARBOPLATIN DOSED BY AREA-UNDER-THE-CURVE - A CANCER-RESEARCH CAMPAIGN PHASE I II COMMITTEE STUDY/, Seminars in oncology, 23(6), 1996, pp. 34-44

Authors: BLEEHEN NM NEWLANDS ES LEE SM THATCHER N SELBY P CALVERT AH RUSTIN GJS BRAMPTON M STEVENS MFG

Citation: Nm. Bleehen et al., CANCER-RESEARCH CAMPAIGN PHASE-II TRIAL OF TEMOZOLOMIDE IN METASTATICMELANOMA, Journal of clinical oncology, 13(4), 1995, pp. 910-913

Authors: LEDERMANN JA HOLDEN L NEWLANDS ES BEGENT RHJ RUSTIN GJS BAGSHAWE KD BRAMPTON M

Citation: Ja. Ledermann et al., THE LONG-TERM OUTCOME OF PATIENTS WHO RELAPSE AFTER CHEMOTHERAPY FOR NONSEMINOMATOUS GERM-CELL TUMORS, British Journal of Urology, 74(2), 1994, pp. 225-230

Authors: BLEEHEN NM CALVERT AH LEE SM HARPER P KAYE SB JUDSON I BRAMPTON M

Citation: Nm. Bleehen et al., A CANCER-RESEARCH CAMPAIGN (CRC) PHASE-II TRIAL OF CB10-277 GIVEN BY 24-HOUR INFUSION FOR MALIGNANT-MELANOMA, British Journal of Cancer, 70(4), 1994, pp. 775-777

Authors: OREILLY SM NEWLANDS ES GLASER MG BRAMPTON M RICEEDWARDS JM ILLINGWORTH RD RICHARDS PG KENNARD C COLQUHOUN IR LEWIS P STEVENS MFG

Citation: Sm. Oreilly et al., TEMOZOLOMIDE - A NEW ORAL CYTOTOXIC CHEMOTHERAPEUTIC AGENT WITH PROMISING ACTIVITY AGAINST PRIMARY BRAIN-TUMORS, European journal of cancer, 29A(7), 1993, pp. 940-942